Status:
UNKNOWN
Diagnostic Value of Anti-MCV in Pts With RA
Lead Sponsor:
Assiut University
Conditions:
Anti-MCV in Rheamatoid Arthritis
Eligibility:
All Genders
18-75 years
Brief Summary
The aim of this work is to evaluate the diagnostic value of anti-MCV antibodies in rheamatoid arthritis patients and to correlate its relationtion disease activity and manifestations.
Detailed Description
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by joint inflammation, subsequent joint destruction leading to loss of joint function, and disability. Joint erosions d...
Eligibility Criteria
Inclusion
- . All patients were previously diagnosedaccording to the 2010 ACR/EULAR RA classification .. with both ( early and late ) rheamatoid arthritis
Exclusion
- patients with other autoimmune disease .
- patient with renal diseaes .
Key Trial Info
Start Date :
September 15 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2019
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT03265236
Start Date
September 15 2017
End Date
February 1 2019
Last Update
August 29 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.